UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
Monopar Therapeutics
MNPR
$799M
| $141K | ﹤0.01% |
6,423
+5,911
| +1,154% | +$99.2K |
|
6652
Metagenomi Therapeutics
MGX
$46.3M
| $141K | ﹤0.01% |
39,050
+29,989
| +331% | +$72.4K |
|
6653
Global X Aging Population ETF
AGNG
$89.1M
| $141K | ﹤0.01% |
+4,658
| New | +$148K |
|
6654
Fidelity MSCI Materials Index ETF
FMAT
$611M
| $140K | ﹤0.01% |
2,913
-834
| -22% | -$44K |
|
|
GIFI
6655
DELISTED
Gulf Island Fabrication
GIFI
| $140K | ﹤0.01% |
20,528
+13,832
| +207% | +$88.1K |
|
6656
Geospace Technologies
GEOS
$75.7M
| $140K | ﹤0.01% |
13,925
+7,977
| +134% | +$88.8K |
|
|
SLAI
6657
DELISTED
SOLAI Ltd ADS
SLAI
| $139K | ﹤0.01% |
+7,898
| New | +$156K |
|
6658
NACCO Industries
NC
$320M
| $139K | ﹤0.01% |
4,663
-156
| -3% | -$4.63K |
|
6659
Pangaea Logistics
PANL
$485M
| $139K | ﹤0.01% |
25,936
+7,544
| +41% | +$45.4K |
|
6660
Turkcell
TKC
$4.79B
| $139K | ﹤0.01% |
21,336
+18,928
| +786% | +$123K |
|
|
LUNA
6661
DELISTED
Luna Innovations Incorporated
LUNA
| $139K | ﹤0.01% |
64,167
+53,240
| +487% | +$94.2K |
|
|
MRNS
6662
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $139K | ﹤0.01% |
258,944
+256,686
| +11,368% | +$179K |
|
6663
FVCBankcorp
FVCB
$333M
| $139K | ﹤0.01% |
11,021
+3,214
| +41% | +$42.6K |
|
6664
Shattuck Labs
STTK
$694M
| $138K | ﹤0.01% |
114,352
-110,414
| -49% | -$137K |
|
|
CLSD
6665
DELISTED
Clearside Biomedical
CLSD
| $138K | ﹤0.01% |
+9,675
| New | +$159K |
|
6666
Invesco AAA CLO Floating Rate Note ETF
ICLO
$526M
| $138K | ﹤0.01% |
+5,363
| New | +$138K |
|
6667
VictoryShares Dividend Accelerator ETF
VSDA
$251M
| $137K | ﹤0.01% |
2,702
-3,627
| -57% | -$192K |
|
|
THRD
6668
DELISTED
Third Harmonic Bio
THRD
| $137K | ﹤0.01% |
13,316
+2,431
| +22% | +$30.3K |
|
6669
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$158M
| $136K | ﹤0.01% |
2,831
+2,058
| +266% | +$101K |
|
6670
CALL
DigitalBridge
DBRG
$2.95B
| $135K | ﹤0.01% |
12,000
| – | – |
|
6671
Richtech Robotics
RR
$360M
| $135K | ﹤0.01% |
49,950
+30,658
| +159% | +$27.6K |
|
6672
CALL
Global Payments
GPN
$22.8B
| $134K | ﹤0.01% |
1,200
| – | – |
|
|
6673
PUT
Global Payments
GPN
$22.8B
| $134K | ﹤0.01% |
1,200
| – | – |
|
|
BRFS
6674
DELISTED
BRF SA
BRFS
| $134K | ﹤0.01% |
32,976
-130,789
| -80% | -$568K |
|
6675
AC Immune
ACIU
$240M
| $134K | ﹤0.01% |
49,678
+35,050
| +240% | +$110K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.